Neuromodulation trials

qEEG Brain Signature of Depression & Neuromodulation-induced Recovery

RecruitingNCT06719427Phase: PHASE1Started 2025-01-06

Summary

This study aims to explore how repetitive transcranial magnetic stimulation (rTMS), a treatment for depression, affects brain function. Depression disrupts the brain's complex network or regions that

Eligibility

Sex
ALL
Min Age
18 Years
Max Age
80 Years

Locations

Sunnybrook Health Sciences CentreNorth York, Ontario, Canada
Sunnybrook Health Sciences CentreToronto, Ontario, Canada

View full study details on ClinicalTrials.gov

clinicaltrials.gov/study/NCT06719427